CD24 and head and neck squamous cell carcinoma: Furthermore, the percentage of CD24 + cells correlated with cisplatin resistance in HNSCC cell lines, and CD24 knockdown significantly reduced NANOG expression and sensitized cells to cisplatin treatment.